DESMOPLASTIC SMALL ROUND CELL TUMOR (DSRCT)

Clinical trials for DESMOPLASTIC SMALL ROUND CELL TUMOR (DSRCT) explained in plain language.

Never miss a new study

Get alerted when new DESMOPLASTIC SMALL ROUND CELL TUMOR (DSRCT) trials appear

Sign up with your email to follow new studies for DESMOPLASTIC SMALL ROUND CELL TUMOR (DSRCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test Triple-Drug attack on devastating youth cancer

Disease control Ongoing

This early-stage study is testing whether adding three new drugs (irinotecan, temozolomide, and bevacizumab) to the standard high-dose chemotherapy can help control a rare and aggressive cancer called Desmoplastic Small Round Cell Tumor (DSRCT). The main goal is to see if this co…

Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR (DSRCT)

Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

DESMOPLASTIC SMALL ROUND CELL TUMOR (DSRCT)

Get alerted when new DESMOPLASTIC SMALL ROUND CELL TUMOR (DSRCT) trials appear

Scientists test Triple-Drug attack on devastating youth cancer